AccuTheranostics Overview
- Founded
-
2012

- Status
-
Private
- Employees
-
4

- Latest Deal Type
-
Accelerator/Inc
- Latest Deal Amount
-
$62.5K
- Investors
-
4
AccuTheranostics General Information
Description
Provider of biomedical and clinical services intended to provide essential information for the treatment of an individual patient's cancer. The company's biomedical and clinical services include specialized chemo-sensitive and chemoresistance assays using a patient's own tumor cells in a laboratory to identify which drugs have the most and the least, potential for treating a patient's unique cancer, enabling physicians to avoid the use of specific chemotherapy agents to which the patient's tumor is resistant and select those that will be most effective.
Contact Information
Website
www.accutheranostics.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Primary Office
- 875 Ellicott Street
- Suite 5086
- Buffalo, NY 14203
- United States
+1 (716) 000-0000
AccuTheranostics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
4. Accelerator/Incubator | 08-Sep-2017 | $62.5K | 000.00 | Completed | Generating Revenue | |
3. Accelerator/Incubator | 01-Jan-2016 | Completed | Generating Revenue | |||
2. Accelerator/Incubator | Completed | Generating Revenue | ||||
1. Accelerator/Incubator | 24-Oct-2012 | Completed | Generating Revenue |
AccuTheranostics Executive Team (3)
AccuTheranostics Signals
AccuTheranostics Investors (4)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Launch NY | Venture Capital | Minority | 000 0000 | 000000 0 | |
43North | Accelerator/Incubator | Minority | 000 0000 | 000000 0 | |
UB Incubator | Accelerator/Incubator | Minority | 000 0000 | 000000 0 | |
The InVentures Group | Accelerator/Incubator | Minority | 000 0000 | 000000 0 |